Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran

Journal of Medical Microbiology

Volumn 64, Issue 7, 2015, Pages 767-773

  Farsiani, Hadi ^a,b   Mosavat, Arman ^a,b   Soleimanpour, Saman ^a,b   Nasab, Mahbobeh Naderi ^a,b   Salimizand, Himen ^a,b   Jamehdar, Saeid Amel ^a,b   Ghazvini, Kiarash ^a,b   Aryan, Ehsan ^a,b   Baghani, Ali Asghar ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE MODIFYING ENZYME; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; ENZYME; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; TRANSPOSON;

5' UNTRANSLATED REGION; AADA1 GENE; ACINETOBACTER BAUMANNII; ADEB GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APHA1 GENE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA ADV GENE; BLA TEM GENE; BLA VIM GENE; CONTROLLED STUDY; EPSILOMETER TEST; GENE INSERTION; GENETIC VARIABILITY; HUMAN; INFECTION CONTROL; IRAN; NONHUMAN; OXA 23 GENE; OXA 51 GENE; OXA 58 GENE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TETA GENE; TETB GENE; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG EFFECTS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; TEACHING HOSPITAL; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COLISTIN; CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENETIC VARIATION; HOSPITALS, TEACHING; HUMANS; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; TETRACYCLINE RESISTANCE;

EID: 84938368728     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000090     Document Type: Article

References (47)

1. Aghazadeh, M, Rezaee, M. A, Nahaei, M. R, Mahdian, R, Pajand, O, Saffari, F, Hassan, M. and Hojabri, Z. (2013). Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among Acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist 19, 282-288.
2. Al-Agamy, M. H, Khalaf, N. G, Tawfick, M. M, Shibl, A. M. and El Kholy, A. (2014). Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22, 49-54.
3. Aliakbarzade, K, Farajnia, S, Karimi Nik, A, Zarei, F. and Tanomand, A. (2014). Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates. Jundishapur J Microbiol 7, e11924.
4. Asadollahi, K, Taherikalani, M, Maleki, A, Alizadeh, E, Valadbaigi, H, Soroush, S, Maleki, H, Asadollahi, P. and Emaneini, M. (2011). Diversity of aminoglycoside modifying enzyme genes among multidrug resistant Acinetobacter baumannii genotypes isolated from nosocomial infections in Tehran hospitals and their association with class 1 integrons. Acta Microbiol Immunol Hung 58, 359-370.
5. Asadollahi, P, Akbari, M, Soroush, S, Taherikalani, M, Asadollahi, K, Sayehmiri, K, Maleki, A, Maleki, M. H, Karimi, P. and Emaneini, M. (2012). Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns 38, 1198-1203.
6. Bou, G, Cervero, G, Dominguez, M. A, Quereda, C. and Martinez-Beltran, J. (2000). PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem-and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 6, 635-643.
7. Bouvet, P. J. and Grimont, P. A. (1987). Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 138, 569-578.
8. Chaudhary, M. (2012). Molecular characterization and antimicrobial susceptibility study of Acinetobacter baumannii clinical isolates from Middle East, African and Indian patients. J Proteomics Bioinform 5, 265-269.
9. CLSI (2012). Performance Standards for Antimicrobial Susceptibility Testing, 22nd Informational Supplement M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute.
10. Dijkshoorn, L, Nemec, A. and Seifert, H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5, 939-951.
11. Ellington, M. J, Kistler, J, Livermore, D. M. and Woodford, N. (2007). Multiplex PCR for rapid detection of genes encoding acquired metallo-ß-lactamases. J Antimicrob Chemother 59, 321-322.
12. Erdem, H, Inan, A, Alt ndis, S, Carevic, B, Askarian, M, Cottle, L, Beovic, B, Csomos, A, Metodiev, K. and other authors (2014). Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran—a prospective multicenter point prevalence study. J Infect 68, 131-140.
13. Fallah, F, Noori, M, Hashemi, A, Goudarzi, H, Karimi, A, Erfanimanesh, S. and Alimehr, S. (2014). Prevalence of blaNDM, blaPER, blayEB, blaIMP, and blavIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica (Cairo) 2014, 245-162.
14. Farajnia, S, Azhari, F, Alikhani, M. Y, Hosseini, M. K, Peymani, A. and Sohrabi, N. (2013). Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in north-west of Iran. Iran J Basic Med Sci 16, 751-755.
15. Feizabadi, M. M, Fathollahzadeh, B, Taherikalani, M, Rasoolinejad, M, Sadeghifard, N, Aligholi, M, Soroush, S. and Mohammadi-Yegane, S. (2008). Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn J Infect Dis 61, 274-278.
16. Go, E. S, Urban, C, Burns, J, Kreiswirth, B, Eisner, W, Mariano, N, Mosinka-Snipas, K. and Rahal, J. J. (1994). Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344, 1329-1332.
17. Guardabassi, L, Dijkshoorn, L, Collard, J. M, Olsen, J. E. and Dalsgaard, A. (2000). Distribution and in-vitro transfer of tetracycline resistancedeterminants in clinical and aquatic Acinetobacter strains. J Med Microbiol 49, 929-936.
18. Héritier, C, Poirel, L, Lambert, T. and Nordmann, P. (2005). Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 49, 3198-3202.
19. Higgins, P. G, Dammhayn, C, Hackel, M. and Seifert, H. (2010). Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65, 233-238.
20. Hujer, K. M, Hujer, A. M, Hulten, E. A, Bajaksouzian, S, Adams, J. M, Donskey, C. J, Ecker, D. J, Massire, C, Eshoo, M. W. and other authors (2006). Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50, 4114-4123.
21. Huys, G, Cnockaert, M, Vaneechoutte, M, Woodford, N, Nemec, A, Dijkshoorn, L. and Swings, J. (2005). Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol 156, 348-355.
22. Karaiskos, I. and Giamarellou, H. (2014). Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother 15, 1351-1370.
23. Kim, U. J, Kim, H. K, An, J. H, Cho, S. K, Park, K. H. and Jang, H. C. (2014). Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med j. 50, 37-44.
24. Magiorakos, A. P, Srinivasan, A, Carey, R. B, Carmeli, Y, Falagas, M. E, Giske, C. G, Harbarth, S, Hindler, J. F, Kahlmeter, G. and other authors (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18, 268-281.
25. Mahon, C. R, Lehman, D. C, Manuselis, G., (2011). Nonfermenting and miscellaneous Gram-negative bacilli. Textbook of Diagnostic Microbiology, 4th edn, pp. 482-502.
26. Maleki, M. H, Sekawi, Z, Soroush, S, Azizi-Jalilian, F, Asadollahi, K, Mohammadi, S, Emaneini, M. and Taherikalani, M. (2014). Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iran/Basic Med Sci 17, 21-26.
27. Nasrolahei, M, Zahedi, B, Bahador, A, Saghi, H, Kholdi, S, Jalalvand, N. and Esmaeili, D. (2014). Distribution of blaOXA-23, ISAba, aminoglycosides resistant genes among burned and ICU patients in Tehran and Sari, Iran. Ann Clin Microbiol Antimicrob 13, 38.
28. Nemec, A, Dolzani, L, Brisse, S, van den Broek, P. and Dijkshoorn, L. (2004). Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol 53, 1233-1240.
29. Noppe-Leclercq, I, Wallet, F, Haentjens, S, Courcol, R. and Simonet, M. (1999). PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res Microbiol 150, 317-322.
30. Peymani, A, Nahaei, M. R, Farajnia, S, Hasani, A, Mirsalehian, A, Sohrabi, N. and Abbasi, L. (2011). High prevalence of metallo-beta-lactamase-producing Iinetobacter baumannii a teaching hospital in Tabriz, Iran. .Jpn Infect Dis 64, 69-71.
31. Peymani, A., Higgins, P.G., Nahaei, M.R., Farajnia, S, and Seifert, H.(2012). Characterisation and clonal dissemination of OXA-23-producingAcinetobacter baumannii in Tabriz, northwest Iran. Int J Antimicrob Agents 39,526-528.
32. Rahal, J. J. (2006). Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43 (Suppl. 2), S95-S99.
33. Ramirez, M. S. and Tolmasky, M. E. (2010). Aminoglycoside modifying enzymes. Drug Resist Updat 13, 151-171.
34. Salimizand, H, Menbari, S, Ramazanzadeh, R, Khonsha, M. and Vahedi, M. S. (2014). DNA fingerprinting and antimicrobial susceptibility pattern of clinical and environmental Acinetobacter baumannii isolates: a multicentre study. J Chemother 21, 1973947814Y0000000227.
35. Salimizand, H, Noori, N, Meshkat, Z, Ghazvini, K. and Jamehdar Amel, S. (2015). Prevalence of Acinetobacter baumannii harboring ISAba1/blaOXA-23-like family in a burn center. Burns 41, 1100-1106.
36. Segal, H, Garny, S. and Elisha, B. G. (2005). Is ISABA-1 customized for Acinetobacter7. FEMS Microbiol Lett 243, 425-429.
37. Shahcheraghi, F, Abbasalipour, M, Feizabadi, M, Ebrahimipour, G. and Akbari, N. (2011). Isolation and genetic characterization of metallo-b-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 3, 68-74.
38. Shakibaie, M. R, Adeli, S. and Salehi, M. H. (2012). Antibiotic resistance patterns and extended-spectrum b-lactamase production among Acinetobacter spp. isolated from an intensive care unit of a hospital in Kerman, Iran. Antimicrob Resist Infect Control 1,1.
39. Soleimanpour, S, Hamedi-Asl, D, Tadayon, K, Farazi, A. A, Keshavarz, R, Soleymani, K, Seddighinia, F. S. and Mosavari, N. (2014). Extensive genetic diversity among clinical isolates of Mycobacterium tuberculosis in central province of Iran. Tuberc Res Treat 2014, 195-287.
40. Srinivasan, V. B, Rajamohan, G, Pancholi, P, Stevenson, K, Tadesse, D, Patchanee, P, Marcon, M. and Gebreyes, W. A. (2009). Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbiol Antimicrob 8, 21.
41. Turton, J. F, Ward, M. E, Woodford, N, Kaufmann, M. E, Pike, R, Livermore, D. M. and Pitt, T. L. (2006a). The role of ISAbaJ in expression of OxA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258, 72-77.
42. Turton, J. F, Woodford, N, Glover, J, Yarde, S, Kaufmann, M. E. and Pitt, T. L. (2006b). Identification of Acinetobacter baumannii by detection of the bla OxA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44, 2974-2976.
43. Vila, J, Marti, S. and Sanchez-Cespedes, J. (2007). Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59, 1210-1215.
44. Visca, P, Seifert, H. and Towner, K. J. (2011). Acinetobacter infection— an emerging threat to human health. IUBMB Life 63, 1048-1054.
45. Woodford, N, Ellington, M. J, Coelho, J. M, Turton, J. F, Ward, M. E, Brown, S, Amyes, S. G. and Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OxA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351-353.
46. Yan, Z.-Q, Shen, D.-X, Cao, J.-R, Chen, R, Wei, X, Liu, L.-P. and Xu, X. L. (2010). Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China. Int J Antimicrob Agents 35, 269-273.
47. Yoon, E. J, Courvalin, P. and Grillot-Courvalin, C. (2013). RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother 57, 2989-2995.